Investors

Axela is a research and diagnostic tools company distinguished by: a proprietary technology, a distinctive business model and a seasoned management team that has successfully commercialized many Life Science tools & diagnostic products in the past. The underlying dot® technology of the company’s first-generation dotLab® System protein assay platform is uniquely positioned to provide researchers with research tools to generate tomorrow’s diagnostic opportunities.

  • Kimberlay-Clark
  • VenGrowth
  • Royal bay Capital
  • MMV Financials
  • MDC Partners
  • Investment Saskatchewan

The company has a number of ongoing collaborations which have generated data in the areas of cardiology, oncology, infectious disease and vaccine immune response that have the potential to address large, underserved diagnostic markets. The company is currently participating in two sponsor-funded clinical trials.

For Investor inquiries, please contact:

Owen Gordon
Axela Inc.
480 University Avenue
Suite 910
Toronto, ON M5G 1V2
Canada

Phone: 416-260-3103
Toll Free: 866-94-AXELA (29352)
Fax: 416-260-9255

No email inquiries, please.